John Irwin Ph.D.
University of California San Francisco, Department of Pharmaceutical Chemistry
Tuesday, September 6, 2022 - 4:00pm
MSB 4171
Special Seminar
Abstract:
Molecular docking is a pragmatic approach to exploit protein structure
for novel ligand discovery. In the past few years, the number of
molecules that can be easily docked, purchased and tested at low cost
has grown from a few million to a few billion, enabling the discovery
of new chemistry for new biology. This presentation will describe this
approach and some of the freely available tools arising from our
research. It will also show how compounds discovered using this
approach have led to new understanding of the biology of the melatonin
receptor and the sigma-2 receptor.
Host:
Dr. Matthieu Schapira
Pharmacology and Toxicology Seminar
Poster: